PATENT CLAIM ANALYSIS

Application Number: 16025832
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "006200"]

Abstract:
A composition in the form of an injectable aqueous solution, the pH of which is between 6.0 and 8.0, includes at least a basal insulin, the isoelectric point pI of which is between 5.8 and 8.5; and a dextran substituted by radicals carrying carboxylate charges and hydrophobic radicals. Single-dose formulations at a pH of between 7 and 7.8 includes a basal insulin whose isoelectric point is between 5.8 and 8.5 and a prandial insulin.

Claim (Index 7):
The composition according to  claim 1 , wherein the dextran polymers substituted by radicals carrying carboxylate charges and hydrophobic radicals is chosen from the dextran polymers of formula I in which the X radical is an at least divalent radical resulting from an amino acid chosen from the group consisting of glycine, leucine, phenylalanine, lysine, isoleucine, alanine, valine, aspartic acid and glutamic acid.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 95.0
- Lexical Diversity: 1.77778
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13571026', '15899795', '15616470', '15616128', '14922663']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.855653342873163
- 35 USC 102 Novelty (BERT): 0.7194403306830214
- Combined Prediction Score: 0.8420320416541488
- Mean Citation Score: 575.206164
- Max Citation Score: 816.0116
- Similarity Product: 777.8987992969514

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test